Mitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cells

Basit Öğe Kaydı
dc.contributor.authorHekmatshoar, Yalda
dc.contributor.authorÖzkan, Tülin
dc.contributor.authorKarabay, Arzu Zeynep
dc.contributor.authorKoç, Aslı
dc.contributor.authorGürel, A. Karadağ
dc.contributor.authorVignais, Marie-Luce
dc.contributor.authorSunguroğlu, A.
dc.date.accessioned2024-11-15T11:42:53Z
dc.date.available2024-11-15T11:42:53Z
dc.date.issued2024en_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri, Tıbbi Biyoloji Ana Bilim Dalıen_US
dc.description.abstract...en_US
dc.identifier.citationHekmatshoar, Y., Özkan, T., Karabay, A. Z., Koç, A., Gürel, A. K., Vignais, M. -L., Sunguroglu, A. (2024). Mitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cells. Toxicology Letters, 399, S91-S91. 10.1016/j.toxlet.2024.07.241en_US
dc.identifier.endpageS91en_US
dc.identifier.issn0378-4274
dc.identifier.issn1879-3169
dc.identifier.startpageS91en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12939/5005
dc.identifier.volume399en_US
dc.identifier.wosWOS:001325675700216
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.institutionauthorHekmatshoar, Yalda
dc.language.isoen
dc.publisherElsevieren_US
dc.relation.ispartofToxicology Letters
dc.relation.isversionof10.1016/j.toxlet.2024.07.241en_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectToxicologyen_US
dc.titleMitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cells
dc.typeOther

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Temel Tıp Bilimleri Bölümü Koleksiyonu